Cargando…
Stromal p16 expression is significantly increased in endometrial carcinoma
p16 is a negative regulator of cell proliferation and is considered a tumor suppressor protein. Alterations in p16 protein expression are associated with tumor development and progression. However, the p16 expression status in the peritumoral stroma has not been investigated in the endometrium. Ther...
Autores principales: | Yoon, Gun, Koh, Chang Won, Yoon, Nara, Kim, Ji-Ye, Kim, Hyun-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354874/ https://www.ncbi.nlm.nih.gov/pubmed/27902476 http://dx.doi.org/10.18632/oncotarget.13594 |
Ejemplares similares
-
Stromal p16 expression is significantly increased in malignant ovarian neoplasms
por: Yoon, Nara, et al.
Publicado: (2016) -
Clinical outcomes of advanced-stage glassy cell carcinoma of the uterine cervix: a need for reappraisal
por: Yoon, Nara, et al.
Publicado: (2016) -
The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers
por: Choi, Yoon Sung, et al.
Publicado: (2015) -
Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma
por: Su, Li, et al.
Publicado: (2015) -
Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast
por: Choi, Eun Ji, et al.
Publicado: (2013)